- New medicines achieve unprecedented weight reduction by mimicking natural hormones and reprogramming vital appetite signals
For decades, the public narrative around weight loss has been dominated by a simple, often demoralizing equation; eat less, move more. Failure was generally blamed on a lack of willpower. Today, a new class of medication, named “miracle shots,” has changed this conversation, offering hope to millions by achieving unprecedented weight reduction. These medicines like semaglutide ( Ozempic & Wegovy) and tirzepatide ( Mounjaro & Zepbound) don’t simply suppress appetite; they represent an intricate chemical intervention, reprogramming our body fundamental hormonal physiology.
As a Physilogist, I believe it is critical for the public to understand how these treatments work; from the vital connection between your gut and your brain, to the crucial role of hormones (glucagon-like peptid and Glucose-Dependent Insulinotropic Polypeptide). More importantly, as these drugs fly off the shelves, we must confront the ethical and physiological dangers of their misuse, ensuring they remain a powerful medical tool for treating chronic disease and not merely taken as a cosmetic shortcut.
The power of these drugs lies in mimicking natural hormones human produce after eating, called incretins. One of the most important of these is Glucagon-Like Peptide-1. It is your body natural “I’m Full” signal, released by the gut in response to food intake. The new medications like Ozempic are simply much stronger, long-lasting copies of this signal. They primarily work in two ways. First, they signal directly to the appetite center in your brain, effectively turning down the appetite control switch, so you feel less desire to eat. Second, they slow down the movement of food from your stomach into your intestine. This leaves you feeling full for much longer, naturally reducing your calorie intake without a constant struggle of willpower.
Some of the newer medicines like Mounjaro in this class take the mechanism a step further by mimicking an additional important gut hormone, called Glucose-Dependent Insulinotropic Polypeptide. By acting on both the GLP-1 and the GIP receptors, these dual agonists achieve an even more profound effect. While GLP-1 is the dominant force for appetite reduction, GIP plays a supportive role, especially by improving better storage of fats in the body. This dual action provides a more complete metabolic reset, which is why these medications are often highly effective not just for weight loss, but for improving markers of health like blood sugar and blood pressure.
No medical tool is without physiological cost. The most common side effects; nausea, vomiting and diarrhea, are a direct result of the intended mechanism of action of the medicine. It slows down the digestive system. If the movement of food out of the stomach is too slow, it can cause discomfort. This is why doctors recommend starting at a low dose and gradually increasing it, giving the body time to adjust to this new, slower pace of digestion. More serious, though rarer, risks include issues like gallbladder disease, low blood sugar and thyroid cancer, which is why consistent medical monitoring is essential.
This brings us to the critical public health issue, which is the increasing misuse of these drugs purely for cosmetic weight loss. These medications are designed to treat chronic metabolic diseases like obesity and Type 2 Diabetes. When they are used by individuals with a lower body mass index (BMI) or without medical supervision, the risks become much harder to justify. Firstly, it creates a severe ethical dilemma by contributing to a global shortage, preventing access for patients with chronic diseases who rely on the medicine for their health and longevity. Secondly, there are serious physiological dangers. When weight loss is rapid and extreme, particularly without professional guidance on nutrition and exercise, a large proportion of the weight lost is often muscle mass rather than just fat. Losing muscle mass is highly detrimental because muscle tissue is the engine of your metabolism; losing it makes it much harder to keep the weight off in the long run because of decreased metabolism and additionally, increases the risk of weakness and frailty.
Nevertheless, these new medicines are extraordinary advancements in treating the complex, hormone-driven disease of obesity. However, they are a powerful tool, not a magical cure. They work best when they provide the body with the hormonal balance necessary to support sustainable lifestyle changes. For anyone considering them, whether for a chronic condition or simply for weight management, it is paramount to consult a qualified healthcare professional, prioritize muscle-preserving habits like strength training and high-protein intake and recognize that any medical therapy must be approached responsibly and not as a trend. The goal, therefore, is not merely a lower number on the scale or achieving a trending look, but rather fostering a healthier, more balanced metabolic system.
The writer is a Sr. Instructor Physiology, Aga Khan University